FutureTech II Acquisition Corp. - FTII

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2023 · Q2 2023
Value (USD)
Total reported value ($000)
$24.9M
QoQ value delta ($000)
-$48.77M (-66.2%)
Implied price effect (QoQ)
+1.84%
Shares
Total shares
2,286,985
QoQ shares delta
-4,603,195 (-66.81%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (FTII)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2023)

Top 25 only Full list
Early Q4 2024 data: only 3 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
WOLVERINE ASSET MANAGEMENT LLC 5,442 500,192 0.06%
Calamos Advisors LLC 5,440 500,000 0.03%
BANK OF MONTREAL /CAN/ 4,076 375,000 0.0%
Polar Asset Management Partners Inc. 3,462 317,000 0.08%
AQR Arbitrage LLC 2,290 210,508 0.1%
Walleye Capital LLC 1,537 140,715 0.0%
Saba Capital Management, L.P. 1,489 136,553 0.04%
Walleye Trading LLC 864 79,151 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 173 15,947 0.0%
STATE STREET CORP 121 11,100 0.0%
UBS Group AG 8 819 0.0%